免疫调节益生菌

Search documents
2025年免疫调节益生菌品牌推荐:引领下一代微生态疗法浪潮
Tou Bao Yan Jiu Yuan· 2025-07-09 12:14
Investment Rating - The report indicates a positive investment outlook for the immune-regulating probiotics industry, highlighting significant growth potential driven by increasing consumer health awareness and demand for immune health products [4]. Core Insights - The immune-regulating probiotics market in China is rapidly developing, with a market size projected to grow from 2.097 billion yuan in 2019 to 5.551 billion yuan in 2024, reflecting a compound annual growth rate (CAGR) of 21.52% [9]. - The report emphasizes the importance of technological innovation and product diversification in meeting evolving consumer demands and enhancing market competitiveness [4][29]. - The industry is witnessing a shift towards local production capabilities, reducing reliance on imported raw materials, which is expected to lower costs and expand market access [11][28]. Market Background - The immune-regulating probiotics market is defined as products that enhance immune response through the modulation of gut microbiota [5]. - The development of this market can be categorized into four phases: nascent, initiation, rapid growth, and maturity, reflecting advancements in scientific understanding and market applications [6][8]. Market Status - The market size for immune-regulating probiotics in China is expected to reach 12.835 billion yuan by 2025 and 21.906 billion yuan by 2029, with a projected CAGR of 14.30% during this period [9]. - The demand for immune health products is driven by a significant portion of the population experiencing decreased immunity, with approximately 80% of residents showing potential demand for immune regulation [12]. Market Competition - The competitive landscape features a tiered structure with leading companies such as Beijing Tongrentang and i-Health in the first tier, followed by Garden of Life and Huada Precision Nutrition in the second tier [13][14]. - The report identifies ten recommended brands, including Beijing Tongrentang, Precision Health, and i-Health, each leveraging unique technological and product innovations to capture market share [15][16][17]. Development Trends - The industry faces challenges related to the diversity of probiotic strains and cost control, with local provinces in China poised to drive the development of localized probiotic products [28]. - Consumer demand is evolving towards diverse product forms, and regulatory reforms are expected to enhance market competition by allowing a wider range of product types [29].